New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 25, 2014
07:39 EDTREGN, RHHBYFears about Regeneron overdone, says RBC Capital
After meeting with with a retina key opinion leader, RBC Capital does not believe that there is a full-scale shift away from Regeneron's (REGN) Elyea to Roche's (RHHBY) Avastin. The firm thinks that Regeneron has a number of upcoming potential major positive catalysts and recommends buying the stock on any pullbacks. It keeps a $349 price target and Outperform rating on the shares.
News For REGN;RHHBY From The Last 14 Days
Check below for free stories on REGN;RHHBY the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 17, 2014
11:00 EDTRHHBYRoche CEO rules out megadeals, focused on bolt-on acquisitions, WSJ says
Roche CEO Severin Schwan said the company won't change its acquisition strategy following the recent deals made or abandoned in the pharmaceutical sector, reports the Wall Street Journal. In an interview with WSJ, Shwan said, "We have been very consistent in our approach to M&A." Regarding transformational deal-making, he said, "We have no intention to do that, whatever happens in the industry." Reference Link
07:43 EDTRHHBYBofA/Merrill to hold a conference
Subscribe for More Information
September 16, 2014
07:31 EDTRHHBYEuropean Association for Study of Diabetes to hold annual meeting
50th Annual Meeting of EASD to be held in Vienna, Austria on September 15-19.
07:31 EDTREGNRegeneron's EYLEA Injection granted designation for treatment of retinopathy
Subscribe for More Information
September 10, 2014
13:04 EDTRHHBYRoche unit receives orphan status for lung cancer mutation drug
Subscribe for More Information
September 8, 2014
07:15 EDTREGN, RHHBYIBC Life Sciences to hold a conference
10th Annual Cell Line Development & Engineering Conference to be held in Berkeley, California on September 8-10.
September 5, 2014
13:07 EDTRHHBYRoche has a conference call hosted by JPMorgan
Subscribe for More Information
September 4, 2014
05:37 EDTREGNRegeneron submits application for Eylea injection in Japan for macular edema
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use